IQVIA Holdings, Inc. is a global leader in advanced analytics, technology solutions, and clinical research services for the life sciences and healthcare sectors. Headquartered in Durham, North Carolina, the company operates in over 100 countries and employs approximately 88,000 to 93,000 professionals. Formed in 2016 from the merger of Quintiles and IMS Health, IQVIA offers a comprehensive range of services through its three core business segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.
IQVIA provides end-to-end solutions that encompass the entire healthcare value chain, from clinical development to commercialization. Its offerings include real-world evidence generation, late-stage clinical trial management, and commercial outsourcing. The company utilizes its proprietary IQVIA Connected Intelligence™ platform, which integrates high-quality health data and advanced analytics, including Healthcare-grade AI™, to deliver insights and optimize healthcare outcomes. IQVIA serves a diverse clientele, including biotechnology firms, pharmaceutical companies, healthcare providers, and government agencies, all aimed at improving patient care and operational efficiency.